TISSUE MATRICES COMPRISING PLACENTAL STEM CELLS
3 Assignments
0 Petitions
Accused Products
Abstract
A method of manufacturing a tissue matrix for implantation into a patient is disclosed. The method sets forth collecting embryonic stem cells from a placenta which has been treated to remove residual cord blood and seeding the collected stem cells onto or into a tissue matrix. The seeded tissue matrix is then implanted on or into a patient. The seeded tissue matrix made by the method of the present invention is also disclosed.
180 Citations
45 Claims
-
1-23. -23. (canceled)
-
24. A tissue matrix comprising isolated CD34−
- , CD10+, SH2+ placental stem cells, wherein said tissue matrix is synthetic.
- View Dependent Claims (25, 26, 27, 28, 29, 30, 31, 32, 33, 34)
-
35. A method of making a tissue matrix, comprising seeding isolated CD34−
- , CD 10+, SH2+ placental stem cells onto a synthetic tissue matrix, wherein said stem cells are from a human placenta that has been drained of cord blood.
- View Dependent Claims (36, 37, 38, 39, 40, 41, 42, 43, 44, 45)
Specification